The Massachusetts Department of Public Health (MDPH) has detected an increase in newly diagnosed HIV infections among persons who inject drugs (PWID) in multiple areas across the Commonwealth. Recent HIV transmission is evidenced by several new cases diagnosed during the acute stage of HIV infection. The primary risk factor reported among identified cases is injection drug use (IDU). Injectable substances linked to this outbreak include heroin, fentanyl, and methamphetamine.

MDPH is asking healthcare providers to enhance their vigilance for, increase their testing of,...

We are delighted to announce a call for applications for the Sustained Training in Aging and HIV Research (STAHR) Program. This program aims to develop promising scientists into high quality independently-funded researchers whose long-term careers will make a lasting contribution to the area of HIV and aging mental health research,...

For more information about the L'Oréal USA For Women in Science program, please visit: www.lorealusa.com/forwomeninscience

To view a PDF of the frequently asked questions regarding the program, please click here.

• Must have a conferred PhD and have started in a postdoctoral research position by February 1, 2019
• Must maintain the status of...

CFAR-RePORT cross-consortia studies to elucidate the role of HIV in TB immunopathogenesis and biomarker delivery

DOWNLOAD the complete RFP: https://cfar.globalhealth.harvard.edu/files/cfar/files/report_cfar_rfp.pdf

Visit the CRDF website for a full application package: http://www....

The 2019-2021 CFAR Adelante application cycle is now open!

Concept Proposals are due on January 7, 2019 
and Full Research Proposals are due on April 16, 2019.

Adelante - meaning forward or onward in Spanish - embodies the primary mission of this mentored research program. Through Adelante, the 

Center for AIDS Research...

The National Institute of Allergy and Infectious Diseases will fund a series of collaborations with medical research institutions in the southern United States to test new ways of implementing HIV treatment and prevention tools in counties with some of the highest rates of new HIV cases nationwide. The U.S. South overall has the highest rates of new HIV diagnoses, people living with HIV, and HIV-related deaths of any U.S. region. 
...

We would like to announce the availability of NIH-funded T32 HIV Research Training Funds to Harvard University available beginning July/August 2019. The goal of the program is to train both MD and PhD investigators for careers in HIV research. Potential areas of investigation include all areas of HIV/AIDS research, ranging from the laboratory to the clinic, including epidemiology, outcomes, implementation, and health policy studies. Funding is available from two Harvard T32 grants, one focused primarily on laboratory based studies (P.I. Dr. Daniel Kuritzkes) and the other on clinical...